Targeting Innate Immune-Polyamine Axis Prevents CKD-Associated Cardiac Hypertrophy

被引：0
|
作者：
Yang, Ke [1 ]
Han, Wenhao [1 ]
Zhu, Yingguo [1 ]
Zhao, Jinghong [1 ]
机构：
[1] Third Mil Med Univ, Army Med Univ, Xinqiao Hosp,Key Lab Prevent & Treatment Chron Ki, Chongqing Clin Res Ctr Kidney & Urol Dis,Dept Nep, Chongqing, Peoples R China
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PO2447
引用
收藏
页码：748 / 748
页数：1
相关论文
共 50 条
  • [1] Innate immunity in CKD-associated vascular diseases
    Zewinger, Stephen
    Schumann, Timo
    Fliser, Danilo
    Speer, Thimoteus
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 (11) : 1813 - 1821
  • [2] Phenotyping CKD-Associated Cardiac Fibrosis
    Narayanan, Gayatri
    Halim, Arvin
    Moe, Sharon M.
    Lu, Tzongshi
    Lim, Kenneth
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 567 - 567
  • [3] Targeting Myocardial Mitochondria- STING-Polyamine Axis Prevents Cardiac Hypertrophy in Chronic Kidney Disease
    Han, Wenhao
    Du, Changhong
    Zhu, Yingguo
    Ran, Li
    Wang, Yue
    Xiong, Jiachuan
    Wu, Yiding
    Lan, Qigang
    Wang, Yaqin
    Wang, Liting
    Wang, Junping
    Yang, Ke
    Zhao, Jinghong
    [J]. JACC-BASIC TO TRANSLATIONAL SCIENCE, 2022, 7 (08): : 820 - 840
  • [4] Targeting Myocardial Mitochondria-STING-Polyamine Axis Prevents Cardiac Hypertrophy in Chronic Kidney Disease (vol 7, pg 820, 2022)
    Han, W.
    Du, C.
    Zhu, Y.
    Ran, L.
    Wang, Y.
    Xiong, J.
    Wu, Y.
    Lan, Q.
    Wang, Y.
    Wang, L.
    Wang, J.
    Yang, K.
    Zhao, J.
    [J]. JACC-BASIC TO TRANSLATIONAL SCIENCE, 2022, 7 (12): : 1284 - 1285
  • [5] DOES FGF23 CONTRIBUTE TO CKD-ASSOCIATED IMMUNE DYSFUNCTION?
    Zawada, Adam M.
    Luthe, Aurelia
    Seiler, Sarah S.
    Rogacev, Kyrill
    Fliser, Danilo
    Heine, Gunnar H.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 413 - 413
  • [6] Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy
    Cipolletta, Ersilia
    Rusciano, Maria Rosaria
    Maione, Angela Serena
    Santulli, Gaetano
    Sorriento, Daniela
    Del Giudice, Carmine
    Ciccarelli, Michele
    Franco, Antonietta
    Crola, Catherine
    Campiglia, Pietro
    Sala, Marina
    Gomez-Monterrey, Isabel
    De Luca, Nicola
    Trimarco, Bruno
    Iaccarino, Guido
    Illario, Maddalena
    [J]. PLOS ONE, 2015, 10 (06):
  • [7] Targeting calcineurin and associated pathways in cardiac hypertrophy and failure
    Fiedler, B
    Wollert, KC
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2005, 9 (05) : 963 - 973
  • [8] Innate Immune Cells in Pressure Overload-Induced Cardiac Hypertrophy and Remodeling
    Liu, Xin
    Shi, Guo-Ping
    Guo, Junli
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [9] Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients
    Silva, Ana Paula
    Mendes, Filipa
    Carias, Eduarda
    Goncalves, Rui Baptista
    Fragoso, Andre
    Dias, Carolina
    Tavares, Nelson
    Cafe, Hugo Mendonca
    Santos, Nelio
    Rato, Fatima
    Neves, Pedro Leao
    Almeida, Edgar
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07)
  • [10] Glioblastoma Immunotherapy Targeting the Innate Immune Checkpoint CD47-SIRPα Axis
    Hu, Jinyang
    Xiao, Qungen
    Dong, Minhai
    Guo, Dongsheng
    Wu, Xudong
    Wang, Baofeng
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
12345